Protalix BioTherapeutics (PLX) Interest Coverage Ratio Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -243.37% |
| Dec 31, 2024 | 178.31% |
| Sep 30, 2024 | 86.20% |
| Jun 30, 2024 | -15.90% |
| Mar 31, 2024 | -34.00% |
| Dec 31, 2023 | -29.74% |
| Sep 30, 2023 | -14.71% |
| Jun 30, 2023 | 43.85% |
| Mar 31, 2023 | -10.30% |
| Dec 31, 2022 | 25.41% |
| Sep 30, 2022 | -18.31% |
| Jun 30, 2022 | -20.10% |
| Mar 31, 2022 | 0.16% |
| Dec 31, 2021 | -1.26% |
| Sep 30, 2021 | 36.04% |
| Jun 30, 2021 | 17.70% |
| Mar 31, 2021 | 27.70% |
| Dec 31, 2020 | 16.39% |
| Sep 30, 2020 | 23.07% |
| Jun 30, 2020 | 33.28% |
| Mar 31, 2020 | 18.25% |
| Mar 31, 2019 | 16.42% |
| Mar 31, 2018 | 62.58% |